4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001567619-23-005285
Chief Executive Officer gave up 98,060 shares (to pay taxes)
- Chief Executive Officer acquired 36,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BIENAIME JEAN JACQUES · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-15 | Grant or award : show line 1 in the form | +36,100 | 523,956 | D | ||
| 2023-03-15 | Shares withheld for taxes : show line 2 in the form | −9,437 | $87.74 | $828,002 | 514,519 | D |
| 2023-03-16 | Shares withheld for taxes : show line 3 in the form | −88,623 | $93.41 | $8,278,274 | 425,896 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-15 | Grant or award : show line 4 in the form Stock Option (Right to buy Common Stock) | +49,430 | 49,430 | D |
Loading xslF345X03/doc1.xml…